Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 3, 2011, Pages

  Mateo, Mathieu ^a   Carbonnelle, Caroline ^a,b   Martinez, Miguel J ^a   Reynard, Olivier ^a   Page, Audrey ^a   Volchkova, Valentina A ^a   Volchkov, Viktor E ^a  

^a UNIVERSITÉ DE LYON   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VP24; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EBOLA VIRUS; ELECTRON MICROSCOPY; GENE SILENCING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; VERO CELL; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS NUCLEOCAPSID; VIRUS RELEASE; VIRUS REPLICATION; WESTERN BLOTTING;

ANIMALS; CERCOPITHECUS AETHIOPS; EBOLAVIRUS; GENE EXPRESSION REGULATION, VIRAL; GENE SILENCING; MICE; NUCLEOCAPSID; RABBITS; RECOMBINANT PROTEINS; VERO CELLS; VIRAL PROTEINS; VIRUS ASSEMBLY; VIRUS REPLICATION;

EID: 80054767647     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir311     Document Type: Article

References (26)

1. Kuhn JH, Becker S, Ebihara H, et al. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol 2010; 155:2083-103.
2. Mohamadzadeh M, Chen L, Schmaljohn AL. How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 2007; 7:556-67. (Pubitemid 46987780)
3. Basler CF, Amarasinghe GK. Evasion of interferon responses by Ebola and Marburg viruses. J Interferon Cytokine Res 2009; 29:511-20.
4. Jones SM, Feldmann H, Stroher U, et al. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med 2005; 11:786-90. (Pubitemid 41021212)
5. Halfmann P, Ebihara H, Marzi A, et al. Replication-deficient Ebolavirus as a vaccine candidate. J Virol 2009; 83:3810-5.
6. Reid SP, Leung LW, Hartman AL, et al. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol 2006; 80:5156-67.
7. Reid SP, Valmas C, Martinez O, Sanchez FM, Basler CF. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J Virol 2007; 1:13469-77. (Pubitemid 350252964)
8. Mateo M, Reid SP, Leung LW, Basler CF, Volchkov VE. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. J Virol 2010; 84:1169-75.
9. Volchkov VE, Chepurnov AA, Volchkova VA, Ternovoj VA, Klenk HD. Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology 2000; 277:147-55.
10. Ebihara H, Takada A, Kobasa D, et al. Molecular determinants of Ebola virus virulence in mice. PLoS Pathog 2006; 2:e73.
11. Watanabe S, Noda T, Halfmann P, Jasenosky L, Kawaoka Y. Ebola virus (EBOV) VP24 inhibits transcription and replication of the EBOV genome. J Infect Dis 2007; 196(suppl 2):S284-90. (Pubitemid 351417273)
12. Hoenen T, Jung S, Herwig A, Groseth A, Becker S. Both matrix proteins of Ebola virus contribute to the regulation of viral genome replication and transcription. Virology 2010; 403:56-66.
13. Huang Y, Xu L, Sun Y, Nabel GJ. The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein. Mol Cell 2002; 10:307-16. (Pubitemid 35007345)
14. Noda T, Ebihara H, Muramoto Y, et al. Assembly and budding of Ebolavirus. PLoS Pathog 2006; 2:e99.
15. Noda T, Halfmann P, Sagara H, Kawaoka Y. Regions in Ebola virus VP24 that are important for nucleocapsid formation. J Infect Dis 2007; 196(suppl 2):S247-50.
16. Valmas C, Grosch MN, Schumann M, et al. Marburg virus evades interferon responses by a mechanism distinct from Ebola virus. PLoS Pathog 2010; 6:e1000721.
17. Bamberg S, Kolesnikova L, Moller P, Klenk HD, Becker S. VP24 of Marburg virus influences formation of infectious particles. J Virol 2005; 79:13421-3.
18. Volchkov VE, Volchkova VA, Muhlberger E, et al. Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science 2001; 291:1965-9. (Pubitemid 32216997)
19. Alazard-Dany N, Volchkova V, Reynard O, et al. Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level. J Gen Virol 2006; 87:1247-57.
20. Halfmann P, Kim JH, Ebihara H, et al. Generation of biologically contained Ebola viruses. Proc Natl Acad Sci U S A 2008; 105:1129-33. (Pubitemid 351397018)
21. Muhlberger E, Weik M, Volchkov VE, Klenk HD, Becker S. Comparison of the transcription and replication strategies of Marburg virus and Ebola virus by using artificial replication systems. J Virol 1999; 73:2333-42. (Pubitemid 29098138)
22. Modrof J, Muhlberger E, Klenk HD, Becker S. Phosphorylation of VP30 impairs Ebola virus transcription. J Biol Chem 2002; 277:33099-104. (Pubitemid 34984826)
23. Martinez MJ, Biedenkopf N, Volchkova V, et al. Role of Ebola virus VP30 in transcription reinitiation. J Virol 2008; 82:12569-73.
24. Hoenen T, Groseth A, Kolesnikova L, et al. Infection of naive target cells with virus-like particles: implications for the function of Ebola virus VP24. J Virol 2006; 80:7260-4. (Pubitemid 44025222)
25. Watanabe S, Noda T, Kawaoka Y. Functional mapping of the nucleoprotein of Ebola virus. J Virol 2006; 80:3743-51.
26. Dalgard DW, Hardy RJ, Pearson SL, et al. Combined simian hemorrhagic fever and Ebola virus infection in cynomolgus monkeys. Lab Anim Sci 1992; 42:152-7.